Evolution of the Average Target: Core Scientific, Inc.

Evolution of the Target Price: Core Scientific, Inc.

Changes in Analyst Recommendations: Core Scientific, Inc.

306e0c1e75bad.7MAB0YaOx1hQuGLh4E7CiiPPISteI15QpqZj8hyGV3g.24NNu6vitnUFlVXZ0naT3XK5ZUw6dhQb6pM7tC_qbhbYjm2T9LzzGz7hBQ~e6782e8a049f4b4c5b0870bfbc1ff543
08:58am UBS Initiates Core Scientific With Buy Rating, $24 Price Target MT
09-21 Rothschild & Co Redburn Initiates Core Scientific at Neutral MT
09-17 Wells Fargo Initiates Core Scientific at Overweight With $28 Price Target MT
08-03 B. Riley Adjusts Price Target on Core Scientific to $42 From $33, Maintain Buy Rating MT
07-30 Keefe Bruyette & Woods Upgrades Core Scientific to Outperform From Market Perform, Adjusts PT to $28 From $25 MT
07-29 Macquarie Adjusts Price Target on Core Scientific to $38 From $35, Maintains Outperform Rating MT
07-27 Keefe, Bruyette & Woods Downgrades Core Scientific to Market Perform From Outperform, Cuts Price Target to $25 From $28 MT
05-27 B. Riley Adjusts Price Target on Core Scientific to $33 From $30, Maintains Buy Rating MT
05-04 U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower RE
03-05 Macquarie Cuts Price Target on Core Scientific to $28 From $34, Keeps Outperform Rating MT
01-06 BTIG Upgrades Core Scientific Inc to Buy From Neutral, Price Target is $23 MT
25-10-31 Core Scientific Well-Positioned to Gain New Customers, Macquarie Says MT
25-10-31 Macquarie Upgrades Core Scientific to Outperform From Neutral, Adjusts Price Target to $34 From $18 MT
25-10-30 Top Midday Stories: Trump, Xi Reach Trade Agreement; Meta Shares Tumble After Analyst Downgrades, Price Target Cuts MT
25-10-28 HC Wainwright Upgrades Core Scientific to Buy From Neutral, Price Target is $25 MT
25-10-23 Roth Capital Upgrades Core Scientific to Buy From Neutral MT
25-10-22 Coreweave comments on proxy advisor recommendations regarding proposed acquisition of Core Scientific RE
25-10-22 B. Riley Upgrades Core Scientific to Buy From Neutral, Raises Price Target to $30 From $17 MT
25-10-21 Core Scientific Rises Pre-Bell as ISS Recommends Investors Reject CoreWeave Deal MT
25-10-07 CoreWeave Doesn't Plan to Change its Bid for Core Scientific MT
25-08-08 Core Scientific's Q2 revenue misses estimates, net loss widens RE
25-07-10 Macquarie Downgrades Core Scientific to Neutral From Outperform, $15 Price Target MT
25-07-10 B. Riley Downgrades Core Scientific Inc to Neutral From Buy, Price Target is $17 MT
25-07-10 Needham Downgrades Core Scientific to Hold From Buy MT
25-07-08 Core Scientific Shares Fall After Multiple Downgrades MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+85.71%
+1.26%
+60.6%
+59.48%
+1.28%
+66.18%
+59.86%
+145.27%
Average +59.95%
Weighted average by Cap. +31.55%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
18.79USD
Average target price
34.35USD
Spread / Average Target
+82.81%
High Price Target
55.00USD
Spread / Highest target
+192.71%
Low Price Target
16.00USD
Spread / Lowest Target
-14.85%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. CORZ Stock
  4. Consensus Core Scientific, Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!